Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Neuropsychiatry Clin Neurosci ; 32(2): 175-184, 2020.
Article in English | MEDLINE | ID: mdl-31266410

ABSTRACT

OBJECTIVE: The prevalence of cavum septum pellucidum (CSP) in mental disorders, particularly schizophrenia spectrum disorders and mood disorders, remains uncertain. The authors used a meta-analytical approach to determine the prevalence of CSP in mental disorders and to compare these with the prevalence of CSP in psychiatrically healthy comparison subjects. METHODS: PubMed and Embase were systematically searched for relevant articles published as of January 9, 2018. After a quality assessment of individual studies using the Newcastle-Ottawa Scale, a random-effects model within Stata statistical software was used to synthesize 25 eligible studies that included 2,392 patients with mental disorders and 1,445 psychiatrically healthy comparison subjects. RESULTS: The prevalence of CSP of any size and large CSP was found to be significantly higher in individuals with mental disorders compared with healthy comparison subjects, and the prevalence of CSP in schizophrenia spectrum and mood disorders did not differ between the groups. CONCLUSIONS: The meta-regression with predefined covariance indicated that imaging parameters were not associated with the heterogeneity among original studies; however, the mean age of enrolled subjects was identified as a possible source of heterogeneity. No publication bias was found.


Subject(s)
Magnetic Resonance Imaging , Mental Disorders/diagnostic imaging , Septum Pellucidum/diagnostic imaging , Humans , Prevalence , Septum Pellucidum/anatomy & histology
2.
J Psychiatr Res ; 116: 126-132, 2019 09.
Article in English | MEDLINE | ID: mdl-31233895

ABSTRACT

Despite evidence of structural brain abnormalities in schizophrenia, the current study aimed to explore the effects of antipsychotic treatment on gray matter (GM) volume using structural magnetic resonance imaging (MRI) and investigate the relationship between brain structure and treatment response. The GM volumes of 33 patients with first-episode schizophrenia were calculated with voxel-based morphometry (VBM), with 33 matched healthy controls. Longitudinal volume changes within subjects after 4-month antipsychotic treatment were also evaluated. Correlation between volumetric changes and clinical symptoms derived from the Positive and Negative Syndrome Scale (PANSS) were further investigated. Compared with healthy controls, decreased GM volumes in the frontal gyrus were observed in schizophrenia patients. After 4-month treatment, patients showed significantly decreased GM volume primarily in the bilateral frontal, temporal and left parietal brain regions. In addition, the GM volume changes of the left postcentral gyrus was positively correlated with negative symptoms improvement, and the correlation analysis revealed the total PANSS scores changes were associated with GM volume changes in the right inferior frontal gyrus and the right superior temporal gyrus. Besides, non-responders had reduced GM volume in the bilateral middle frontal gyrus and the right superior frontal gyrus compared with responders and healthy controls. Our results suggest that the abnormality in the right frontal gyrus exists in the early stage of schizophrenia. Moreover, the relationship between antipsychotics and structural changes was identified. The GM volume might have the potential to reflect the symptom improvement in schizophrenia patients. And MRI may assist in predicting the antipsychotic treatment response in first-episode schizophrenia patients.


Subject(s)
Antipsychotic Agents/pharmacology , Gray Matter/drug effects , Gray Matter/pathology , Outcome Assessment, Health Care , Prefrontal Cortex/drug effects , Prefrontal Cortex/pathology , Schizophrenia/drug therapy , Schizophrenia/pathology , Adult , Follow-Up Studies , Gray Matter/diagnostic imaging , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Male , Prefrontal Cortex/diagnostic imaging , Schizophrenia/diagnostic imaging , Schizophrenia/physiopathology , Young Adult
3.
Schizophr Res ; 208: 160-166, 2019 06.
Article in English | MEDLINE | ID: mdl-30967317

ABSTRACT

OBJECTIVE: We aimed to evaluate the functional network properties in first-episode schizophrenia (SZ) patients at baseline and after 4-months treatment with second-generation antipsychotic drugs. METHODS: Resting-state functional magnetic resonance imaging and graph theory approaches were utilized to evaluate the functional integration and segregation of brain networks in 36 first-episode patients (20 male/16 female) with SZ and 36 age and sex matched healthy controls (20 male/16 female). RESULTS: Compared with healthy controls, SZ at baseline showed lower clustering coefficient (Cp) and local network efficiency (Eloc), and this abnormal pattern was modulated with treatment of antipsychotic drugs at follow-up. Longitudinally, the increase of Cp was associated with the improvement of negative symptom. We found that the strength of functional connectivity between brain regions were significantly increased in three connections after treatment, mainly involving the frontal, parietal and occipital lobes. CONCLUSION: The current study suggested that antipsychotic drugs could modulate the faulty local clustering of the functional connectome in SZ. Furthermore, Cp, the parameter that reflects local clustering of topological organization, demonstrated the potential to be a connectome-based biomarker of treatment response to second-generation antipsychotics in patients with SZ.


Subject(s)
Antipsychotic Agents/therapeutic use , Brain/drug effects , Brain/physiopathology , Magnetic Resonance Imaging , Schizophrenia/drug therapy , Schizophrenia/physiopathology , Adolescent , Adult , Brain/diagnostic imaging , Female , Follow-Up Studies , Humans , Image Processing, Computer-Assisted , Longitudinal Studies , Male , Middle Aged , Neural Pathways/diagnostic imaging , Neural Pathways/drug effects , Neural Pathways/physiopathology , Rest , Schizophrenia/diagnostic imaging , Treatment Outcome , Young Adult
4.
Brain Behav ; 9(2): e01211, 2019 02.
Article in English | MEDLINE | ID: mdl-30701701

ABSTRACT

INTRODUCTION: Treatment response at an early stage of schizophrenia is of considerable value with regard to future management of the disorder; however, there are currently no biomarkers that can inform physicians about the likelihood of response. OBJECTS: We aim to develop and validate regional brain activity derived from functional magnetic resonance imaging (fMRI) as a potential signature to predict early treatment response in schizophrenia. METHODS: Amplitude of low-frequency fluctuation (ALFF) was measured at the start of the first/single episode resulting in hospitalization. Inpatients were included in a principal dataset (n = 79) and a replication dataset (n = 44). Two groups of healthy controls (n = 87; n = 106) were also recruited for each dataset. The clinical response was assessed at discharge from the hospital. The predictive capacity of normalized ALFF in patients by healthy controls, ALFFratio , was evaluated based on diagnostic tests and clinical correlates. RESULTS: In the principal dataset, responders exhibited increased baseline ALFF in the left postcentral gyrus/inferior parietal lobule relative to non-responders. ALFFratio of responders before treatment was significantly higher than that of non-responders (p < 0.001). The area under the receiver operating characteristic curve was 0.746 for baseline ALFFratio to distinguish responders from non-responders, and the sensitivity, specificity, and accuracy were 72.7%, 68.6%, and 70.9%, respectively. Similar results were found in the independent replication dataset. CONCLUSIONS: Baseline regional activity of the brain seems to be predictive of early response to treatment for schizophrenia. This study shows that psycho-neuroimaging holds promise for influencing the clinical treatment and management of schizophrenia.


Subject(s)
Brain/physiopathology , Hospitalization , Magnetic Resonance Imaging/methods , Schizophrenia , Adult , Episode of Care , Female , Humans , Male , Neuroimaging/methods , Outcome Assessment, Health Care , Prognosis , ROC Curve , Schizophrenia/diagnosis , Schizophrenia/physiopathology , Schizophrenia/therapy
5.
Schizophr Bull ; 44(5): 1053-1059, 2018 08 20.
Article in English | MEDLINE | ID: mdl-29471434

ABSTRACT

Specific biomarker reflecting neurobiological substrates of schizophrenia (SZ) is required for its diagnosis and treatment selection of SZ. Evidence from neuroimaging has implicated disrupted functional connectivity in the pathophysiology. We aimed to develop and validate a method of disease definition for SZ by resting-state functional connectivity using radiomics strategy. This study included 2 data sets collected with different scanners. A total of 108 first-episode SZ patients and 121 healthy controls (HCs) participated in the current study, among which 80% patients and HCs (n = 183) and 20% (n = 46) were selected for training and testing in intra-data set validation and 1 of the 2 data sets was selected for training and the other for testing in inter-data set validation, respectively. Functional connectivity was calculated for both groups, features were selected by Least Absolute Shrinkage and Selection Operator (LASSO) method, and the clinical utility of its features and the generalizability of effects across samples were assessed using machine learning by training and validating multivariate classifiers in the independent samples. We found that the accuracy of intra-data set training was 87.09% for diagnosing SZ patients by applying functional connectivity features, with a validation in the independent replication data set (accuracy = 82.61%). The inter-data set validation further confirmed the disease definition by functional connectivity features (accuracy = 83.15% for training and 80.07% for testing). Our findings demonstrate a valid radiomics approach by functional connectivity to diagnose SZ, which is helpful to facilitate objective SZ individualized diagnosis using quantitative and specific functional connectivity biomarker.


Subject(s)
Brain/physiopathology , Connectome/methods , Image Processing, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Schizophrenia/physiopathology , Support Vector Machine , Adult , Brain/diagnostic imaging , Connectome/standards , Female , Humans , Image Processing, Computer-Assisted/standards , Magnetic Resonance Imaging/standards , Male , Reproducibility of Results , Schizophrenia/diagnostic imaging , Support Vector Machine/standards , Young Adult
6.
Sci Rep ; 7(1): 16201, 2017 11 23.
Article in English | MEDLINE | ID: mdl-29170485

ABSTRACT

Neural substrates behind schizophrenia (SZ) and its heritability mediated by brain function are largely unknown. Cerebral blood flow (CBF), as a biomarker of activation in the brain, reflects the neuronal metabolism, and is promisingly used to detect cerebral alteration thereby shedding light on the features of individuals at high genetic risk. We performed a cross-sectional functional magnetic resonance imaging (MRI) study enrolling 45 first-episode drug-naïve patients with SZ, 32 unaffected first-degree relatives of these patients, and 51 healthy controls (HCs). We examined CBF, CBF connectivity, and CBF topological properties. SZ patients showed increased CBF in the left medial superior frontal gyrus and right precuneus compared with HCs, and decreased CBF in the left middle temporal gyrus compared with their relatives. Furthermore, unaffected relatives revealed higher level of CBF pronounced in regions within default mode network (DMN). Both SZ patients and their relatives exhibited dysconnectivity patterns. Notably, as for the network properties, unaffected relatives were with an intermediate level between SZ patients and HCs in the local efficiency and global efficiency. Our findings demonstrate the aberrant CBF of areas within DMN and the CBF connectivity pattern might be a familial feature in the brain of first-episode SZ patients and their relatives.


Subject(s)
Schizophrenia/physiopathology , Adult , Brain/metabolism , Brain/pathology , Brain/physiopathology , Brain Mapping , Cerebrovascular Circulation/physiology , Cross-Sectional Studies , Female , Humans , Magnetic Resonance Imaging , Male , Neural Pathways/physiology , Schizophrenia/metabolism , Schizophrenia/pathology , Young Adult
7.
Neuroreport ; 28(17): 1164-1169, 2017 Dec 06.
Article in English | MEDLINE | ID: mdl-28953093

ABSTRACT

We aimed to detect alterations in diffusion characteristics of brain white matter in hepatic myelopathy (HM) patients. Liver cirrhosis patients with (n=25) and without (n=18) HM after transjugular intrahepatic portosystemic shunt and 26 healthy controls were enrolled in this study. All participants were scanned with diffusion tensor imaging on a 3T Siemens scanner. Tract-based spatial statistics analysis was used to detect abnormalities of intracranial white matter tracts. Correlations between clinical characteristics and diffusion metrics were also calculated. HM patients showed widespread decreased fractional anisotropy values in association fibers, callosal fibers, thalamic fibers, and limbic system fibers (P<0.01, family-wise error-corrected) compared with healthy controls. In addition, HM patients showed lower fractional anisotropy values in the corpus callosum, corona radiata, external capsule, and superior longitudinal fasciculus compared with cirrhosis patients without myelopathy (P<0.01, family-wise error-corrected). Furthermore, limb muscle strength grading was correlated with the diffusion characteristics of the corpus callosum and superior longitudinal fasciculus in HM patients (P<0.05). HM patients suffer from more distinct changes of white matter fiber tracts than cirrhosis patients without myelopathy. In addition, alterations of the corpus callosum and superior longitudinal fasciculus may be associated with the major motor disturbance in HM. Our finding may shed light on the underlying neuropathological mechanism of HM.


Subject(s)
Brain/diagnostic imaging , Hepatic Encephalopathy/diagnostic imaging , Portasystemic Shunt, Transjugular Intrahepatic , Postoperative Complications/diagnostic imaging , Spinal Cord Diseases/diagnostic imaging , White Matter/diagnostic imaging , Adult , Cross-Sectional Studies , Diffusion Magnetic Resonance Imaging , Diffusion Tensor Imaging , Female , Fibrosis/diagnostic imaging , Fibrosis/physiopathology , Fibrosis/surgery , Hepatic Encephalopathy/physiopathology , Humans , Male , Middle Aged , Muscle Strength , Neural Pathways/diagnostic imaging , Postoperative Complications/physiopathology , Spinal Cord Diseases/physiopathology
8.
Schizophr Res ; 173(1-2): 13-22, 2016 May.
Article in English | MEDLINE | ID: mdl-26995674

ABSTRACT

OBJECTIVE: Auditory verbal hallucinations (AVHs) are one of the cardinal symptoms of schizophrenia (SZ). Cerebral dysfunction may represent pathophysiological underpinnings behind AVHs in SZ. However, regional and network functional deficits for AVHs in SZ remain to be identified. METHODS: Seventeen medication-naïve first-episode SZ patients with AVHs, 15 without AVHs, and 19 healthy controls (HCs) were studied using resting-state functional magnetic resonance imaging. We compared the amplitude of low-frequency fluctuation (ALFF) and regional homogeneity (ReHo) among these subjects. Areas with both ALFF and ReHo alterations were used as seeds in functional connectivity (FC) analysis. Then we performed correlation analysis between image measures and symptoms and receiver operating characteristic analysis. RESULTS: One-way analysis of variance showed significant differences of ALFF and ReHo in the bilateral putamen, thereby being used as seeds. SZ patients with AVHs showed decreased ALFF in the left putamen, increased ReHo in the right dorsolateral prefrontal cortex (DLPFC), and increased right putamen-seeded FC with the left DLPFC and Broca's area relative to those without AVHs. Furthermore, the increased strength of the connectivity between the right putamen and left Broca's area correlated with the severity of SZ symptoms. Both patient groups demonstrated hypoconnectivity within frontal/parietal/temporal cortico-striatal-cerebellar networks compared with HCs. CONCLUSION: AVHs in SZ may be caused by abnormal regional function in the putamen and prefrontal cortex, as well as hyperconnectivity between them. The putamen-related regional and network functional deficits may reflect imbalance in neuromodulation of AVHs in SZ. Furthermore, dysconnectivity within cortico-striatal-cerebellar networks might subserve the pathogenesis of SZ.


Subject(s)
Brain Mapping , Hallucinations/etiology , Hallucinations/pathology , Neural Pathways/pathology , Putamen/diagnostic imaging , Schizophrenia/complications , Schizophrenia/pathology , Acoustic Stimulation , Adolescent , Adult , Analysis of Variance , Female , Hallucinations/diagnostic imaging , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Neural Pathways/diagnostic imaging , Oxygen/blood , Psychiatric Status Rating Scales , ROC Curve , Schizophrenia/diagnostic imaging , Statistics as Topic , Young Adult
9.
Front Hum Neurosci ; 9: 589, 2015.
Article in English | MEDLINE | ID: mdl-26578933

ABSTRACT

Understanding the neural basis of schizophrenia (SZ) is important for shedding light on the neurobiological mechanisms underlying this mental disorder. Structural and functional alterations in the anterior cingulate cortex (ACC), dorsolateral prefrontal cortex (DLPFC), hippocampus, and medial prefrontal cortex (MPFC) have been implicated in the neurobiology of SZ. However, the effective connectivity among them in SZ remains unclear. The current study investigated how neuronal pathways involving these regions were affected in first-episode SZ using functional magnetic resonance imaging (fMRI). Forty-nine patients with a first-episode of psychosis and diagnosis of SZ-according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision-were studied. Fifty healthy controls (HCs) were included for comparison. All subjects underwent resting state fMRI. We used spectral dynamic causal modeling (DCM) to estimate directed connections among the bilateral ACC, DLPFC, hippocampus, and MPFC. We characterized the differences using Bayesian parameter averaging (BPA) in addition to classical inference (t-test). In addition to common effective connectivity in these two groups, HCs displayed widespread significant connections predominantly involved in ACC not detected in SZ patients, but SZ showed few connections. Based on BPA results, SZ patients exhibited anterior cingulate cortico-prefrontal-hippocampal hyperconnectivity, as well as ACC-related and hippocampal-dorsolateral prefrontal-medial prefrontal hypoconnectivity. In summary, spectral DCM revealed the pattern of effective connectivity involving ACC in patients with first-episode SZ. This study provides a potential link between SZ and dysfunction of ACC, creating an ideal situation to associate mechanisms behind SZ with aberrant connectivity among these cognition and emotion-related regions.

SELECTION OF CITATIONS
SEARCH DETAIL
...